MINT-RIZATRIPTAN ODT
MINT PHARMACEUTICALS INC
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is MINT-RIZATRIPTAN ODT discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that MINT-RIZATRIPTAN ODT 5MG has been permanently discontinued (last updated July 1, 2017). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is MINT-RIZATRIPTAN ODT not available?
The reason the manufacturer reported: Business reasons.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
MAXALT RPD
ORGANON CANADA INC.
RIZATRIPTAN ODT
SIVEM PHARMACEUTICALS ULC
MAR-RIZATRIPTAN ODT
MARCAN PHARMACEUTICALS INC
RIZATRIPTAN RDT
PRO DOC LIMITEE
TEVA-RIZATRIPTAN ODT
TEVA CANADA LIMITED
MAXALT
ORGANON CANADA INC.
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
02439573
Strength
5MG
Dosage Form
TABLET (ORALLY DISINTEGRATING)
Route
ORAL
Compare with another product →
Shortage History
Other Products from MINT PHARMACEUTICALS INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
300MG · DIN 02480956
10MG · DIN 02468840
25MG · DIN 02468859
200MG · DIN 02524708
400MG · DIN 02524716
800MG · DIN 02524724
70.0MG · DIN 02394871
5MG · DIN 02362651
10MG · DIN 02362678
1MG · DIN 02393573
5MG · DIN 02495449
2.5MG · DIN 02495430